Edwards Lifesciences Corp (NYSE:EW)
$ 75.38 0.57 (0.76%) Market Cap: 44.12 Bil Enterprise Value: 40.45 Bil PE Ratio: 10.80 PB Ratio: 4.62 GF Score: 84/100

Edwards Lifesciences Corp at Wells Fargo Healthcare Conference Transcript

Sep 08, 2022 / 01:45PM GMT
Release Date Price: $95.52 (+3.85%)
Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst

All right. Good morning, everyone. I'm Larry Biegelsen, in the medical device analyst at Wells Fargo. It's my pleasure to host this session with Edwards Lifesciences.

With us, we have Scott Ullem, the CFO; and Mark Wilterding, Head of Investor Relations. In terms of format, it's going to be a fireside chat. If anyone has a question they want me to ask or they want to ask, just raise your hand and we'll call on you. So Scott, thanks so much for being here.

Scott B. Ullem
Edwards Lifesciences Corporation - Corporate VP & CFO

It's our pleasure. Thanks for having us.

Questions & Answers

Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst

So Scott, we're starting all these fireside chats with the macro environment, no surprise. Edwards was impacted in the second quarter, right, some macro challenges like contrast

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot